Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Doc groups say payer promises not enough to address care denials
MGMA and others who are part of the “Regulatory Relief Coalition” are urging Congress to continue pushing forward with the Improving Seniors’ Timely Access to Care Act.
Russian researcher strategizes on collaboration with China over healthcare AI
Have you ever wondered what China and Russia would talk about if they were to discuss AI in healthcare? It turns out they do just that—and a newly published academic paper straight out of the Russian Federation offers a glimpse into the dialogue.
10-second brain MRI scans possible with newly FDA-cleared deep learning reconstruction software
The artificial intelligence-enabled software offers accelerated acquisition times, improved image resolution and one-click workflows for technologists.
'Technical issue' prevents providers from receiving alerts on actionable imaging findings for 3 years
The system uses color coded flags to alert general practitioners that a patient's imaging report contains "serious or unexpected” findings.
FDA shares warning after Johnson & Johnson heart pump controllers linked to 3 deaths
Johnson & Johnson MedTech has received reports of its Automated Impella Controller failing to connect properly with Impella heart pumps. If this happens, the FDA warned, it may put patients at risk.

Nanox shares up 63% after scoring FDA clearance for new imaging system

The Nanox.ARC utilizes novel, cold-cathode X-ray tubes and charges physicians using a “pay per scan” business model.

cardiologist doctor physician patient black diverse hypertension

Q&A: Why the future of physician payments is looking brighter

Health Exec caught up with Claire Ernst from MGMA to learn more about the possibility of physician payments being tied to inflation in the future.

Heart surgeon charged with 'professional incompetency,' harmful practices

The surgeon, who now lives in a different state, has 20 days to respond to allegations made by the Iowa Board of Medicine.

The FDFA has cleared tirzepatide (Mounjaro) from Eli Lilly for the treatment of diabetes.

Eli Lilly targets FDA approval for weight loss medication

Tirzepatide, sold under the name Mounjaro, is among a handful of drugs with big buzz for their weight loss results, and approval for obesity could be a huge revenue source for Eli Lilly in the future.

American College of Radiology issues heads-up on possible payment denials at certain facility types

ACR is urging providers who encounter such denials to contact their local Medicare Administrative Contractor and consults related CMS documents.

ACR applauds FDA about-face on use of iodinated contrast in children

The update marks a change from the FDA's stance on the topic last year.

CMS to punish hospitals sooner for price transparency noncompliance

Several studies have found that compliance is low with the government's new price transparency regulations. CMS hopes these newly announced changes can make a difference.

AI-based prostate cancer management technology makes official debut in clinical settings

The recently FDA-cleared program merges patient-specific information from prostate imaging, biopsies and pathology, resulting in a deep learning algorithm that creates an AI-generated 3D map of cancer.

Policy & Regulations

Doc groups say payer promises not enough to address care denials

Russian researcher strategizes on collaboration with China over healthcare AI

10-second brain MRI scans possible with newly FDA-cleared deep learning reconstruction software

'Technical issue' prevents providers from receiving alerts on actionable imaging findings for 3 years

FDA shares warning after Johnson & Johnson heart pump controllers linked to 3 deaths